Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sacubitril/Valsartan in Advanced CKD with Heart Failure
NCT03771729Phase 1Unknown
- Sponsor
- The 2nd Affiliated Hospital of Harbin Medical University
- Start
- Dec 2018
- Primary completion
- May 2019
- Modality
- Small Molecules
01
Overview
Phase 1, open-label, single-arm trial of sacubitril + valsartan in heart failure (HF) and chronic kidney disease (CKD), sponsored by The 2nd Affiliated Hospital of Harbin Medical University. Primary endpoints: Change in estimated glomerular filtration rate at 12 weeks, Change in urinary microalbumin/creatinine ratio at 12 weeks and 1 more. Status: unknown.
02
Drugs
sacubitril + valsartan
03
Conditions
heart failure (HF)chronic kidney disease (CKD)
Beyond the preview
Go deeper on NCT03771729.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03771729.